Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1093

1.

Imaging Soft-tissue Sarcomas of the Head and Neck: A Tertiary Soft-tissue Sarcoma Unit Experience.

Jaly AA, Thway K, Touska P, Wale A, Miah A, Kerawala C, Riva F, Moskovic E, Jones RL, Strauss D, Dafydd DA, Messiou C.

Anticancer Res. 2019 Nov;39(11):6223-6230. doi: 10.21873/anticanres.13831.

PMID:
31704851
2.

Negative phase III trials announce the need for biomarkers in sarcoma.

Lee AT, Huang PH, Jones RL.

Eur J Cancer. 2019 Oct 29;123:81-82. doi: 10.1016/j.ejca.2019.08.035. [Epub ahead of print] No abstract available.

PMID:
31675613
3.

The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib.

Wilding CP, Elms ML, Judson I, Tan AC, Jones RL, Huang PH.

Expert Rev Anticancer Ther. 2019 Nov 13:1-21. doi: 10.1080/14737140.2019.1686979. [Epub ahead of print]

PMID:
31665941
4.

CT imaging improves histopathological grading of retroperitoneal leiomyosarcomas.

Mcaddy NC, Hallin M, Strauss D, Smith M, Hayes A, Yusuf S, Moskovic E, Fotiadis N, van Houdt W, Jones RL, Gronchi A, Thway K, Messiou C.

Eur J Surg Oncol. 2019 Oct 10. pii: S0748-7983(19)30888-1. doi: 10.1016/j.ejso.2019.10.007. [Epub ahead of print]

PMID:
31653457
5.

The adequacy of tissue microarrays in the assessment of inter- and intra-tumoural heterogeneity of infiltrating lymphocyte burden in leiomyosarcoma.

Lee ATJ, Chew W, Wilding CP, Guljar N, Smith MJ, Strauss DC, Fisher C, Hayes AJ, Judson I, Thway K, Jones RL, Huang PH.

Sci Rep. 2019 Oct 10;9(1):14602. doi: 10.1038/s41598-019-50888-5.

6.

Phage constructs targeting gonadotropin-releasing hormone for fertility control: evaluation in cats.

Johnson AK, Jones RL, Kraneburg CJ, Cochran AM, Samoylov AM, Wright JC, Hutchinson C, Picut C, Cattley RC, Martin DR, Samoylova TI.

J Feline Med Surg. 2019 Sep 30:1098612X19875831. doi: 10.1177/1098612X19875831. [Epub ahead of print]

PMID:
31566070
7.

Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network.

Frezza AM, Assi T, Lo Vullo S, Ben-Ami E, Dufresne A, Yonemori K, Noguchi E, Siontis B, Ferraro R, Teterycz P, Duffaud F, Ravi V, Vincenzi B, Gelderblom H, Pantaleo MA, Baldi GG, Desar I, Fedenko A, Maki RG, Jones RL, Benjamin RS, Blay JY, Kawai A, Gounder M, Gronchi A, Le Cesne A, Mir O, Czarnecka AM, Schuetze S, Wagner AJ, Adam J, Barisella M, Sbaraglia M, Hornick JL, Meurgey A, Mariani L, Casali PG, Thornton K, Stacchiotti S.

Cancer. 2019 Sep 19. doi: 10.1002/cncr.32508. [Epub ahead of print]

PMID:
31536651
8.

Characterising low-cost sensors in highly portable platforms to quantify personal exposure in diverse environments.

Chatzidiakou L, Krause A, Popoola OAM, Di Antonio A, Kellaway M, Han Y, Squires FA, Wang T, Zhang H, Wang Q, Fan Y, Chen S, Hu M, Quint JK, Barratt B, Kelly FJ, Zhu T, Jones RL.

Atmos Meas Tech. 2019;12(8):4643-4657. doi: 10.5194/amt-12-1-2019. Epub 2019 Aug 30.

9.

Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance.

van Houdt WJ, Husson O, Patel A, Jones RL, Smith MJF, Miah AB, Messiou C, Moskovic E, Al-Muderis O, Benson C, Zaidi S, Dunlop A, Strauss DC, Hayes AJ, van der Graaf WTA.

Ann Surg Oncol. 2019 Sep 17. doi: 10.1245/s10434-019-07826-6. [Epub ahead of print]

PMID:
31531797
10.

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.

Jones RL, Ratain MJ, O'Dwyer PJ, Siu LL, Jassem J, Medioni J, DeJonge M, Rudin C, Sawyer M, Khayat D, Awada A, de Vos-Geelen JMPGM, Evans TRJ, Obel J, Brockstein B, DeGreve J, Baurain JF, Maki R, D'Adamo D, Dickson M, Undevia S, Geary D, Janisch L, Bedard PL, Abdul Razak AR, Kristeleit R, Vitfell-Rasmussen J, Walters I, Kaye SB, Schwartz G.

Eur J Cancer. 2019 Oct;120:132-139. doi: 10.1016/j.ejca.2019.07.024. Epub 2019 Sep 12.

11.

The Role of Local Therapy in Multi-focal Epithelioid Haemangioendothelioma.

Tong D, Constantinidou A, Engelmann B, Chamberlain F, Thway K, Fisher C, Hayes A, Fotiadis N, Messiou C, Miah AB, Zaidi SH, Benson C, VAN DER Graaf W, Jones RL.

Anticancer Res. 2019 Sep;39(9):4891-4896. doi: 10.21873/anticanres.13675.

PMID:
31519592
12.

Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.

Jones RL, Maki RG, Patel SR, Wang G, McGowan TA, Shalaby WS, Knoblauch RE, von Mehren M, Demetri GD.

Cancer. 2019 Sep 10. doi: 10.1002/cncr.32462. [Epub ahead of print]

PMID:
31503332
13.

Sarcomas and old age: few options for such a large patient population.

Jones RL.

Future Oncol. 2019 Sep 10. doi: 10.2217/fon-2019-0489. [Epub ahead of print]

PMID:
31500445
14.

Toward a Unified Terminology of Processing Levels for Low-Cost Air-Quality Sensors.

Schneider P, Bartonova A, Castell N, Dauge FR, Gerboles M, Hagler GSW, Hüglin C, Jones RL, Khan S, Lewis AC, Mijling B, Müller M, Penza M, Spinelle L, Stacey B, Vogt M, Wesseling J, Williams RW.

Environ Sci Technol. 2019 Aug 6;53(15):8485-8487. doi: 10.1021/acs.est.9b03950. Epub 2019 Jul 29. No abstract available.

PMID:
31353903
15.

Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma Centre.

Drabbe C, Benson C, Younger E, Zaidi S, Jones RL, Judson I, Chisholm J, Mandeville H, Fisher C, Thway K, Al Muderis O, Messiou C, Strauss D, Husson O, Miah A, Van der Graaf WTA.

Clin Oncol (R Coll Radiol). 2019 Jul 23. pii: S0936-6555(19)30287-0. doi: 10.1016/j.clon.2019.07.007. [Epub ahead of print]

PMID:
31350181
16.

Associations among particulate matter, hazardous air pollutants and methane emissions from the Aliso Canyon natural gas storage facility during the 2015 blowout.

Garcia-Gonzales DA, Popoola O, Bright VB, Paulson SE, Wang Y, Jones RL, Jerrett M.

Environ Int. 2019 Nov;132:104855. doi: 10.1016/j.envint.2019.05.049. Epub 2019 Jun 26.

17.

First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1.

Somaiah N, Block MS, Kim JW, Shapiro GI, Do KT, Hwu P, Eder JP, Jones RL, Lu H, Ter Meulen JH, Bohac C, Chen M, Hsu FJ, Gnjatic S, Pollack SM.

Clin Cancer Res. 2019 Oct 1;25(19):5808-5817. doi: 10.1158/1078-0432.CCR-19-1025. Epub 2019 Jun 21.

PMID:
31227504
18.

Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas).

Sanfilippo R, Jones RL, Blay JY, Le Cesne A, Provenzano S, Antoniou G, Mir O, Fucà G, Fumagalli E, Bertulli R, Stacchiotti S, Brahmi M, Grosso F, Dufresne A, Hindi N, Sbaraglia M, Gronchi A, Collini P, Dei Tos AP, Casali PG.

Clin Cancer Res. 2019 Sep 1;25(17):5295-5300. doi: 10.1158/1078-0432.CCR-19-0288. Epub 2019 Jun 19.

PMID:
31217199
19.

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.

Berlow NE, Rikhi R, Geltzeiler M, Abraham J, Svalina MN, Davis LE, Wise E, Mancini M, Noujaim J, Mansoor A, Quist MJ, Matlock KL, Goros MW, Hernandez BS, Doung YC, Thway K, Tsukahara T, Nishio J, Huang ET, Airhart S, Bult CJ, Gandour-Edwards R, Maki RG, Jones RL, Michalek JE, Milovancev M, Ghosh S, Pal R, Keller C.

BMC Cancer. 2019 Jun 17;19(1):593. doi: 10.1186/s12885-019-5681-6.

20.

Molecular partitioning in ternary solutions of cellulose.

Zhang X, Mao Y, Tyagi M, Jiang F, Henderson D, Jiang B, Lin Z, Jones RL, Hu L, Briber RM, Wang H.

Carbohydr Polym. 2019 Sep 15;220:157-162. doi: 10.1016/j.carbpol.2019.05.054. Epub 2019 May 23.

PMID:
31196535
21.

Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial.

Zhang S, Kohli K, Black RG, Yao L, Spadinger SM, He Q, Pillarisetty VG, Cranmer LD, Van Tine BA, Yee C, Pierce RH, Riddell SR, Jones RL, Pollack SM.

Cancer Immunol Res. 2019 Aug;7(8):1237-1243. doi: 10.1158/2326-6066.CIR-18-0940. Epub 2019 Jun 6.

PMID:
31171504
22.

Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.

Younger E, Ballman K, Lu Y, Pápai Z, Van Tine BA, Attia S, Schöffski P, Reinke D, Tap WD, Jones RL.

J Geriatr Oncol. 2019 May 22. pii: S1879-4068(18)30464-8. doi: 10.1016/j.jgo.2019.05.008. [Epub ahead of print]

PMID:
31126845
23.

Pazopanib in advanced soft tissue sarcomas.

Lee ATJ, Jones RL, Huang PH.

Signal Transduct Target Ther. 2019 May 17;4:16. doi: 10.1038/s41392-019-0049-6. eCollection 2019. Review.

24.

Effects of hydroxychloroquine on the human placenta-Findings from in vitro experimental data and a systematic review.

Scott RE, Greenwood SL, Hayes DJL, Baker BC, Jones RL, Heazell AEP.

Reprod Toxicol. 2019 Aug;87:50-59. doi: 10.1016/j.reprotox.2019.05.056. Epub 2019 May 10.

PMID:
31082466
25.

A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.

Jones RL, Chawla SP, Attia S, Schöffski P, Gelderblom H, Chmielowski B, Le Cesne A, Van Tine BA, Trent JC, Patel S, Wagner AJ, Chugh R, Heyburn JW, Weil SC, Wang W, Viele K, Maki RG.

Cancer. 2019 Jul 15;125(14):2445-2454. doi: 10.1002/cncr.32084. Epub 2019 Apr 29.

26.

Correction.

Brook A, Hoaksey A, Gurung R, Yoong EEC, Sneyd R, Baynes GC, Bischof H, Jones S, Higgins LE, Jones C, Greenwood SL, Jones RL, Gram M, Lang I, Desoye G, Myers J, Schneider H, Hansson SR, Crocker IP, Brownbill P.

FASEB J. 2019 May;33(5):6682. doi: 10.1096/fj.201800264RERR. No abstract available.

PMID:
31034282
27.

Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.

Chamberlain FE, Wilding C, Jones RL, Huang P.

Expert Opin Investig Drugs. 2019 Jun;28(6):505-511. doi: 10.1080/13543784.2019.1607291. Epub 2019 Apr 22. Review.

PMID:
31010343
28.

Bisexual Lives and Aging in Context: A Cross-National Comparison of the United Kingdom and the United States.

Jen S, Jones RL.

Int J Aging Hum Dev. 2019 Jul;89(1):22-38. doi: 10.1177/0091415019843661. Epub 2019 Apr 18. No abstract available.

PMID:
30997826
29.

Failure of Decidualization and Maternal Immune Tolerance Underlies Uterovascular Resistance in Intra Uterine Growth Restriction.

Dunk C, Kwan M, Hazan A, Walker S, Wright JK, Harris LK, Jones RL, Keating S, Kingdom JCP, Whittle W, Maxwell C, Lye SJ.

Front Endocrinol (Lausanne). 2019 Mar 20;10:160. doi: 10.3389/fendo.2019.00160. eCollection 2019.

30.

Aldoxorubicin in soft tissue sarcomas.

Chamberlain FE, Jones RL, Chawla SP.

Future Oncol. 2019 May;15(13):1429-1435. doi: 10.2217/fon-2018-0922. Epub 2019 Mar 15. Review.

PMID:
30873850
31.

Differential effect of LPS and IL-1β in term placental explants.

Duval C, Brien ME, Gaudreault V, Boufaied I, Baker B, Jones RL, Girard S.

Placenta. 2019 Jan;75:9-15. doi: 10.1016/j.placenta.2018.11.006. Epub 2018 Nov 22.

PMID:
30712669
32.

Treatment of Desmoid Tumors in 2019.

Gronchi A, Jones RL.

JAMA Oncol. 2019 Apr 1;5(4):567-568. doi: 10.1001/jamaoncol.2018.6449. No abstract available.

PMID:
30703188
33.

Use of a Mouse Model of Experimentally Induced Endometriosis to Evaluate and Compare the Effects of Bisphenol A and Bisphenol AF Exposure.

Jones RL, Lang SA, Kendziorski JA, Greene AD, Burns KA.

Environ Health Perspect. 2018 Dec;126(12):127004. doi: 10.1289/EHP3802.

34.

Very low-level prenatal mercury exposure and behaviors in children: the HOME Study.

Patel NB, Xu Y, McCandless LC, Chen A, Yolton K, Braun J, Jones RL, Dietrich KN, Lanphear BP.

Environ Health. 2019 Jan 9;18(1):4. doi: 10.1186/s12940-018-0443-5.

35.

Gemcitabine Re-challenge in Metastatic Soft Tissue Sarcomas: A Therapeutic Option for Selected Patients.

Sebio A, Constantinidou A, Benson C, Antoniou G, Messiou C, Miah A, Zaidi S, Petruckevitch A, Al-Muderis O, Thway K, VAN DER Graaf WT, Jones RL.

Anticancer Res. 2019 Jan;39(1):347-351. doi: 10.21873/anticanres.13118.

PMID:
30591479
36.

Ending 40 years of silence: Rationale for a new staging system for soft tissue sarcoma of the head and neck.

Hahn E, Huang SH, Hosni A, Razak AA, Jones RL, Dickson BC, Sturgis EM, Patel SG, O'Sullivan B.

Clin Transl Radiat Oncol. 2018 Nov 27;15:13-19. doi: 10.1016/j.ctro.2018.11.009. eCollection 2019 Feb. Review.

37.

Optimising Cancer Vaccine Design in Sarcoma.

Pender A, Jones RL, Pollack S.

Cancers (Basel). 2018 Dec 20;11(1). pii: E1. doi: 10.3390/cancers11010001. Review.

38.

LAMP: A CDC Program to Ensure the Quality of Blood-Lead Laboratory Measurements.

Caldwell KL, Cheng PY, Vance KA, Makhmudov A, Jarrett JM, Caudill SP, Ho DP, Jones RL.

J Public Health Manag Pract. 2019 Jan/Feb;25 Suppl 1, Lead Poisoning Prevention:S23-S30. doi: 10.1097/PHH.0000000000000886.

PMID:
30507766
39.

Alarmins at the maternal-fetal interface: involvement of inflammation in placental dysfunction and pregnancy complications 1.

Brien ME, Baker B, Duval C, Gaudreault V, Jones RL, Girard S.

Can J Physiol Pharmacol. 2019 Mar;97(3):206-212. doi: 10.1139/cjpp-2018-0363. Epub 2018 Nov 28. Review.

PMID:
30485131
40.

Exposure-response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcoma.

Jones RL, Mo G, Baldwin JR, Peterson PM, Ilaria RL Jr, Conti I, Cronier DM, Tap WD.

Cancer Chemother Pharmacol. 2019 Jan;83(1):191-199. doi: 10.1007/s00280-018-3723-4. Epub 2018 Nov 8.

41.

Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review.

Riedel RF, Jones RL, Italiano A, Bohac C, Thompson JC, Mueller K, Khan Z, Pollack SM, Van Tine BA.

Cancers (Basel). 2018 Nov 1;10(11). pii: E417. doi: 10.3390/cancers10110417. Review.

42.

Age-related sarcoma patient experience: results from a national survey in England.

Younger E, Husson O, Bennister L, Whelan J, Wilson R, Roast A, Jones RL, van der Graaf WT.

BMC Cancer. 2018 Oct 17;18(1):991. doi: 10.1186/s12885-018-4866-8.

43.

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Bielack S, Abecassis N, Aro HT, Bauer S, Biagini R, Bonvalot S, Boukovinas I, Bovee JVMG, Brennan B, Brodowicz T, Broto JM, Brugières L, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Dhooge C, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gaspar N, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hecker-Nolting S, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kager L, Kasper B, Kopeckova K, Krákorová DA, Ladenstein R, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Morland B, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Strauss SJ, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee, PaedCan and ERN EURACAN.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv79-iv95. doi: 10.1093/annonc/mdy310. No abstract available.

44.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv268-iv269. doi: 10.1093/annonc/mdy321. No abstract available.

45.

Decidual leucocytes infiltrating human spiral arterioles are rich source of matrix metalloproteinases and degrade extracellular matrix in vitro and in situ.

Choudhury RH, Dunk CE, Lye SJ, Harris LK, Aplin JD, Jones RL.

Am J Reprod Immunol. 2019 Jan;81(1):e13054. doi: 10.1111/aji.13054. Epub 2018 Sep 29.

PMID:
30267451
46.

Trends in Modern Phase 1 Oncology Trials.

Jones RL.

N Engl J Med. 2018 Sep 20;379(12):1188-9. doi: 10.1056/NEJMc1808907. No abstract available.

PMID:
30260158
47.

Pregnancy outcome in mothers over the age of 35.

Heazell AEP, Newman L, Lean SC, Jones RL.

Curr Opin Obstet Gynecol. 2018 Dec;30(6):337-343. doi: 10.1097/GCO.0000000000000494.

PMID:
30239372
48.

Preserving quality of life as a key treatment goal in advanced soft tissue sarcomas.

Jones RL, Le Cesne A, Ibrahim T, Garcia Del Muro X, Menge F.

Expert Rev Anticancer Ther. 2018 Dec;18(12):1241-1248. doi: 10.1080/14737140.2018.1524298. Epub 2018 Sep 26. Review.

PMID:
30220224
49.

Synovial Sarcoma of the Thyroid Gland, Diagnostic Pitfalls and Clinical Management.

Owen C, Constantinidou A, Miah AB, Thway K, Fisher C, Benson C, Zaidi S, Messiou C, VAN DER Graaf WTA, Jones RL.

Anticancer Res. 2018 Sep;38(9):5275-5282. doi: 10.21873/anticanres.12853. Review.

PMID:
30194178
50.

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv267. doi: 10.1093/annonc/mdy320. No abstract available.

Supplemental Content

Loading ...
Support Center